SF-36
SF-36 is a behavioral intervention with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Proof of Concept Open Label, Clinical Trial to Evaluate the Safety and Efficacy of the "FITT" Device in Diabetic Foot Ulcers Patients
Hidden Impairments During Subarachnoid Haemorrhage Recovery, Description and Evolution of a Newly Described Syndrom
Characteristics of Hypophosphatasia in Adult Patients in Rheumatology
Supporting Patient Decisions About UE Surgery in Cervical SCI
Comparison of Self-assessment vs. Assessment by Others of Critically Ill Patients
Clinical Trials (8)
Proof of Concept Open Label, Clinical Trial to Evaluate the Safety and Efficacy of the "FITT" Device in Diabetic Foot Ulcers Patients
Hidden Impairments During Subarachnoid Haemorrhage Recovery, Description and Evolution of a Newly Described Syndrom
Characteristics of Hypophosphatasia in Adult Patients in Rheumatology
Supporting Patient Decisions About UE Surgery in Cervical SCI
Comparison of Self-assessment vs. Assessment by Others of Critically Ill Patients
Symptom Based Treatment Affects Brain Plasticity - the Role of Verbal Auditory Hallucinations
Quality of Life Assessment Before and After Essure Removal
Prospective Study of Long-term Outcome After Non-aneurysmal Subarachnoid Hemorrhage
All 8 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 8